← Back to Search

Other

Augmented Reality Assistance for Phlebotomy

N/A

Waitlist Available

Led By Ali H Dhanaliwala, MD, PhD

Research Sponsored by University of Pennsylvania

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at end of procedure, on average 30 minutes

Awards & highlights

Study Summary

This trial tests how a virtual reality headset can help doctors place IVs more accurately.

Who is the study for?

This trial is for adults (18+) who need help placing an IV with ultrasound guidance. It's not suitable for those needing urgent or emergency IV placement.Check my eligibility

What is being tested?

The study tests if using an augmented reality headset to see ultrasound images helps in guiding the insertion of an intravenous catheter more effectively.See study design

What are the potential side effects?

Since this trial involves a non-invasive technology, there may be minimal side effects related to discomfort from wearing the headset or distraction during the procedure.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at end of procedure, on average 30 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at end of procedure, on average 30 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and at end of procedure, on average 30 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Cannulation rate

Secondary outcome measures

Cannulation attempts

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Augmented RealityExperimental Treatment1 Intervention

Subjects in this group will have their intravenous catheter placed while the physician uses a mixed reality headset to view the ultrasound images being used to guide the catheter placement.

Group II: ControlActive Control1 Intervention

Subjects in this group will have their intravenous catheter placed using standard of care. The physician will use the monitor on the ultrasound machine only to view the ultrasound images being used to guide the catheter placement.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor

2,000 Previous Clinical Trials

42,880,088 Total Patients Enrolled

Ali H Dhanaliwala, MD, PhDPrincipal InvestigatorUniversity of Pennsylvania

1 Previous Clinical Trials

20 Total Patients Enrolled

Media Library

Augmented Reality Heads-up Display (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05710445 — N/A

Phlebotomy Clinical Trial 2023: Augmented Reality Heads-up Display Highlights & Side Effects. Trial Name: NCT05710445 — N/A

Augmented Reality Heads-up Display (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05710445 — N/A

Phlebotomy Research Study Groups: Control, Augmented Reality

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any slots available for participants in this trial at present?

"According to the information available on clinicaltrials.gov, recruiting for this study has already been completed. Initially posted in February 1st 2023 and last updated January 23rd, there are currently two other studies that are actively looking for participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Augmented Reality Heads-up Display to Improve Ultrasound Guided IV Access

Ali Dhanaliwala 2023. "Augmented Reality Heads-up Display to Improve Ultrasound Guided IV Access". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05710445.